Skip to main content

Table 1 Demographics at Baseline

From: The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer

Total

 

Histology

N

Percent

Basal Cell

25

56.8%

Squamous cell

17

38.6%

Merckle Cell

1

2.3%

T-Cell Lymphoma

1

2.3%

Tumor Stage

N

Percent

Tis

1

2.3%

T1

39

88.6%

T2

1

2.3%

Recurrence

3

6.8%

Ethnicity

N

Percent

Caucasian/Non-Hispanic

35

94.6%

Hispanic

2

5.4%

Gender

N

Percent

Male

27

73.0%

Female

10

27.0%

Lesion Locations

N

%

Scalp

5

11.4%

Face

14

31.8%

Nose

16

36.4%

Extremity

4

9.1%

Ear

5

11.4%